Climb Bio Retained Earnings vs. Market Capitalization
| CLYM Stock | 1.95 0.08 3.94% |
Retained Earnings | First Reported 2010-12-31 | Previous Quarter -156 M | Current Value -148.2 M | Quarterly Volatility 47.5 M |
For Climb Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Climb Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Climb Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Climb Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Climb Bio over time as well as its relative position and ranking within its peers.
Climb |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Climb Bio. If investors know Climb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Climb Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Climb Bio is measured differently than its book value, which is the value of Climb that is recorded on the company's balance sheet. Investors also form their own opinion of Climb Bio's value that differs from its market value or its book value, called intrinsic value, which is Climb Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Climb Bio's market value can be influenced by many factors that don't directly affect Climb Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Climb Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Climb Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Climb Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Climb Bio Market Capitalization vs. Retained Earnings Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Climb Bio's current stock value. Our valuation model uses many indicators to compare Climb Bio value to that of its competitors to determine the firm's financial worth. Climb Bio is rated fourth in retained earnings category among its peers. It is currently under evaluation in market capitalization category among its peers . Climb Bio reported last year Retained Earnings of (155.98 Million). Comparative valuation analysis is a catch-all technique that is used if you cannot value Climb Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Climb Market Capitalization vs. Retained Earnings
Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Climb Bio |
| = | (155.98 M) |
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Climb Bio |
| = | null |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Climb Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Climb Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Climb Bio will eventually generate negative long term returns. The profitability progress is the general direction of Climb Bio's change in net profit over the period of time. It can combine multiple indicators of Climb Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -40.3 M | -42.3 M | |
| Net Loss | -35.1 M | -36.9 M | |
| Income Before Tax | -35.1 M | -36.9 M | |
| Total Other Income Expense Net | 536 K | 562.8 K | |
| Net Loss | -35.1 M | -36.9 M | |
| Net Interest Income | 4.6 M | 3.3 M | |
| Interest Income | 4.6 M | 3.3 M |
Climb Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Climb Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Climb Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Climb Bio's important profitability drivers and their relationship over time.
| Retained Earnings vs Net Income | ||
| Total Debt vs Market Capitalization | ||
| Retained Earnings vs Number Of Employees | ||
| Total Asset vs Market Capitalization | ||
| Retained Earnings vs Working Capital |
Use Climb Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Climb Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Climb Bio will appreciate offsetting losses from the drop in the long position's value.Climb Bio Pair Trading
Climb Bio Pair Trading Analysis
The ability to find closely correlated positions to Climb Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Climb Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Climb Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Climb Bio to buy it.
The correlation of Climb Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Climb Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Climb Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Climb Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Climb Bio position
In addition to having Climb Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Strategy ETFs Thematic Idea Now
Strategy ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Strategy ETFs theme has 1286 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Strategy ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. To learn how to invest in Climb Stock, please use our How to Invest in Climb Bio guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
To fully project Climb Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Climb Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Climb Bio's income statement, its balance sheet, and the statement of cash flows.